fda warning letter semaglutide october 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA warns consumers not to
Description
The goal is protein-forward snacking rather than keto fat bombs, which tend to displace protein calories
The findings confirmed significant lean mass reductions in larger trials, though they noted that body composition improvements were generally favorable when looking at fat-to-lean ratios
In research models, these pathways are linked to muscle recovery signaling and cellular regeneration responses after physical stress
What makes GLP-1 users unique is the speed and magnitude of their results, which can sometimes magnify visible changes in the skin
